Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-national Real-world Outcomes and Treatment Patterns Study of Lanadelumab (Takhzyro) in Paediatric Patients With Hereditary Angioedema (TAHORA)

NCT07251933 is registered in ClinicalTrials.gov with Takeda as lead sponsor.

NCT NCT07251933
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07251933 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-national Real-world Outcomes and Treatment Patterns Study of Lanadelumab (Takhzyro) in Paediatric Patients With Hereditary Angioedema (TAHORA)
Lead sponsor
Takeda
Phase
Observational
Overall status
Completed
Start date
February 5, 2026
Completion date
July 5, 2026
Enrollment
37 (actual)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

hereditary angioedema (hae)